Trafalgar International (GCAN) Non Operating Interest Expenses (2016 - 2018)
Trafalgar International (GCAN) posted Non Operating Interest Expenses of $14515.0 for Q3 2018, up 554.42% on a QoQ basis from $2218.0 in Q2 2018, and up 2035.33% year-over-year from $679.75 in Q3 2017.
Analysis
Trafalgar International (GCAN) Non Operating Interest Expenses (2016 - 2018) Analysis & Trends
Trafalgar International has reported Non Operating Interest Expenses for 3 years, with the latest figure at $14515.0 in Q3 2018.
- On a quarterly basis, Non Operating Interest Expenses rose 2035.33% year-over-year to $14515.0 in Q3 2018; TTM through Sep 2018 was $16276.0, a 5733.69% increase from a year earlier, with the FY2017 full-year figure at -$4551.0, down 51.7% from the prior year.
- Non Operating Interest Expenses was $14515.0 for Q3 2018 at Trafalgar International, up from $2218.0 in the prior quarter.
- The five-year high for Non Operating Interest Expenses was $14515.0 in Q3 2018, with the low at -$2022.0 in Q4 2017.
- Average Non Operating Interest Expenses over 3 years is $2069.4, with a median of $889.5 recorded in 2017.
- The sharpest annual moves came in 2017 and 2018: Non Operating Interest Expenses sank 169.6% in 2017, then soared 2035.33% in 2018.
- Over 3 years, Non Operating Interest Expenses stood at -$750.0 in 2016, then plunged by 169.6% to -$2022.0 in 2017, then surged by 817.85% to $14515.0 in 2018.
- The last three Non Operating Interest Expenses figures came in at $14515.0 (Q3 2018), $2218.0 (Q2 2018), and $1565.0 (Q1 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -333.60 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 23.78 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 582,000.00 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 2.90 Mn |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 14,515.00 |
| Jun 30, 2018 | 2,218.00 |
| Mar 31, 2018 | 1,565.00 |
| Dec 31, 2017 | -2,022.00 |
| Sep 30, 2017 | -750.00 |
| Jun 30, 2017 | 1,029.00 |
| Mar 31, 2017 | 750.00 |
| Dec 31, 2016 | -750.00 |